Evidence map›Paper›PMID 33244165›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2021

De novo variants in MED12 cause X-linked syndromic neurodevelopmental disorders in 18 females.

D L Polla, E J Bhoj, J B G M Verheij, J S Klein Wassink-Ruiter, A Reis, C Deshpande, A Gregor, K Hill-Karfe, A T Vulto-van Silfhout, R Pfundt and 22 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Case Report: A novelFrontiers in psychiatry · 2026
    Article
  5. Review
  6. Article
  7. Biallelic MED29 variants cause pontocerebellar hypoplasia with cataracts.European journal of human genetics : EJHG · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Novel insights into the phenotypic spectrum and pathogenesis of Hardikar syndrome.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Correspondence on "De novo variants in MED12 cause X-linked syndromic neurodevelopmental disorders in 18 females" by Polla et al.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  20. Response to Riccardi et al.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors at 12 institutions in 7 countries.

D L PollaDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands.
E J BhojDepartment of Pediatrics, Division of Human Genetics and Molecular Biology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
J B G M VerheijDepartment of Medical Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
J S Klein Wassink-RuiterDepartment of Medical Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
A ReisInstitute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
C DeshpandeDepartment of Clinical Genetics, SE Thames Regional Genetics Service, Guy's Hospital, London, UK.
A GregorInstitute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
K Hill-KarfeDepartment of Pediatrics, Division of Human Genetics and Molecular Biology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
A T Vulto-van SilfhoutDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
R PfundtDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
E M H F BongersDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
H HakonarsonDepartment of Pediatrics, Division of Human Genetics and Molecular Biology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
S BerlandDepartment of Medical Genetics, Haukeland University Hospital, Helse Bergen, Norway.
G GradekDepartment of Medical Genetics, Haukeland University Hospital, Helse Bergen, Norway.
S BankaManchester Centre For Genomic Medicine, University of Manchester, St Mary's Hospital, Manchester Academic Health Science Centre, Manchester, UK.
K ChandlerManchester Centre For Genomic Medicine, University of Manchester, St Mary's Hospital, Manchester Academic Health Science Centre, Manchester, UK.
L GompertzManchester Centre For Genomic Medicine, University of Manchester, St Mary's Hospital, Manchester Academic Health Science Centre, Manchester, UK.
S C HuffelsDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands.
C T R M StumpelDepartment of Clinical Genetics and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
R WennekesDepartment of Radiology, Maastricht University Hospital, Maastricht University, Maastricht, The Netherlands.
A P A StegmannDepartment of Clinical Genetics and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
W ReardonDepartment of Clinical Genetics, Children's Health Ireland, Dublin, Ireland.
E K S M LeendersDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
B B A de VriesDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
D LiCenter for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
E ZackaiDepartment of Pediatrics, Division of Human Genetics and Molecular Biology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
N RaggeInternational Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, UK.
S A LynchUCD Academic Centre on Rare Diseases, School of Medicine and Medical Sciences, University College Dublin, and Clinical Genetics, Temple Street Children's University Hospital, Dublin, Ireland.
S CuddapahDepartment of Pediatrics, Division of Human Genetics and Molecular Biology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
H van BokhovenDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands.
C Zweier *Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
A P M de Brouwer *Department of Human Genetics, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands. Arjan.deBrouwer@radboudumc.nl.ORCID http://orcid.org/0000-0002-2131-0484
Radboud University Nijmegen · NLChildren's Hospital of Philadelphia · USFriedrich-Alexander-Universität Erlangen-Nürnberg · DEMaastricht University · NLManchester Academic Health Science Centre · GBHaukeland University Hospital · NOUniversity Medical Center Groningen · NLChildren's Health Ireland at Crumlin · IEGuy's Hospital · GBLondon School of Hygiene & Tropical Medicine · GBMinistry of Education · BRUniversity College Dublin · IE

Funding

Wellcome Trust
6 · The paper itself

Abstract

purposeMED12 is a subunit of the Mediator multiprotein complex with a central role in RNA polymerase II transcription and regulation of cell growth, development, and differentiation. This might underlie the variable phenotypes in males carrying missense variants in MED12, including X-linked recessive Ohdo, Lujan, and FG syndromes.

methodsBy international matchmaking we assembled variant and clinical data on 18 females presenting with variable neurodevelopmental disorders (NDDs) and harboring de novo variants in MED12.

resultsFive nonsense variants clustered in the C-terminal region, two splice variants were found in the same exon 8 splice acceptor site, and 11 missense variants were distributed over the gene/protein. Protein truncating variants were associated with a severe, syndromic phenotype consisting of intellectual disability (ID), facial dysmorphism, short stature, skeletal abnormalities, feeding difficulties, and variable other abnormalities. De novo missense variants were associated with a less specific, but homogeneous phenotype including severe ID, autistic features, limited speech and variable other anomalies, overlapping both with females with truncating variants as well as males with missense variants.

conclusionWe establish de novo truncating variants in MED12 as causative for a distinct NDD and de novo missense variants as causative for a severe, less specific NDD in females.

Indexed as

Intellectual DisabilityNeurodevelopmental DisordersX-Linked Intellectual DisabilityFemaleGenes, X-LinkedHumansMediator ComplexMutation, MissensePhenotypeSyndromeMED12 protein, humanMediator Complex

Identifiers

PMID33244165
OpenAlexW3108422627

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.